Literature DB >> 3499611

B-cell-stimulatory factor 2 (beta 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells.

R D Garman1, K A Jacobs, S C Clark, D H Raulet.   

Abstract

Purified peripheral murine T cells, in the presence of concanavalin A, can be activated to produce interleukin 2 (IL-2) through stimulation either with a previously described murine lymphokine designated T cell-activating factor (TAF) or with a cloned human lymphokine that has been called beta 2 interferon, B-cell-stimulatory factor 2, hybridoma growth factor, inducible 26-kDa protein, or hematopoietic colony-stimulating factor 309 by different investigators. We and others propose the designation interleukin 6 (IL-6) for the latter molecule. Our experiments demonstrate that either murine TAF or human IL-6 can restore the ability of purified T cells to proliferate in response to Con A or antibodies against the T-cell antigen receptor. Most if not all of the proliferation can be blocked by antibodies against the alpha chain of the IL-2 receptor. Furthermore, highly purified CD8- T cells can be activated by IL-6 in the presence of Con A to secrete IL-2. We propose that IL-6 and murine TAF are important "second signals" in primary antigen-receptor-dependent T-cell activation. Whether or not murine TAF is a homologue of human IL-6 remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3499611      PMCID: PMC299353          DOI: 10.1073/pnas.84.21.7629

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

Review 2.  Interleukin 1 and T cell activation.

Authors:  S B Mizel
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

Review 3.  T-cell growth factor.

Authors:  K A Smith
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

Review 4.  Role of lymphokine and antigen in the control of specific T cell responses.

Authors:  K J Lafferty; L Andrus; S J Prowse
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

5.  T-cell growth factor gene: lack of expression in human T-cell leukemia-lymphoma virus-infected cells.

Authors:  S K Arya; F Wong-Staal; R C Gallo
Journal:  Science       Date:  1984-03-09       Impact factor: 47.728

6.  Characterization of a novel murine T cell-activating factor.

Authors:  R D Garman; D H Raulet
Journal:  J Immunol       Date:  1987-02-15       Impact factor: 5.422

7.  The role of accessory cells in polyclonal T cell activation II. Induction of interleukin 2 responsiveness requires cell-cell contact.

Authors:  T Hünig
Journal:  Eur J Immunol       Date:  1983-07       Impact factor: 5.532

8.  T-Cell lymphoma model for the analysis of interleukin 1-mediated T-cell activation.

Authors:  S Gillis; S B Mizel
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

9.  Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones.

Authors:  S C Meuer; J C Hodgdon; R E Hussey; J P Protentis; S F Schlossman; E L Reinherz
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

10.  Interleukin 1 enhances T-dependent immune responses by amplifying the function of dendritic cells.

Authors:  S L Koide; K Inaba; R M Steinman
Journal:  J Exp Med       Date:  1987-02-01       Impact factor: 14.307

View more
  89 in total

1.  Inhibition of tyrosine kinases blocks adhesion-induced T-cell coactivation without interfering with T-cell adhesion to endothelial cell-surface ligands.

Authors:  Dawn M Nowlin; Pina M Cardarelli; Lynn Young; Jason Mah; Katherine A Felts; Marian Mastrangelo; Ronald R Cobb
Journal:  Inflammation       Date:  2002-02       Impact factor: 4.092

2.  On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion.

Authors:  A Ray; K S LaForge; P B Sehgal
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

3.  IL-6 enhances the generation of cytolytic T lymphocytes in the allogeneic mixed leucocyte reaction.

Authors:  J E Ming; R M Steinman; A Granelli-Piperno
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

4.  Interleukin-6 is antiproliferative to a mouse hybridoma cell line and promotive for its antibody productivity.

Authors:  F Makishima; S Terada; T Mikami; E Suzuki
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

5.  Multiple biological activities are expressed by a mouse interleukin 6 cDNA clone isolated from bone marrow stromal cells.

Authors:  C P Chiu; C Moulds; R L Coffman; D Rennick; F Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

6.  Role of interleukin 1 in the activation of T lymphocytes.

Authors:  A H Lichtman; J Chin; J A Schmidt; A K Abbas
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  Interleukin 2-dependent and interleukin 2-independent pathways of regulation of thymocyte function by interleukin 6.

Authors:  J M Le; G Fredrickson; L F Reis; T Diamantstein; T Hirano; T Kishimoto; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

8.  Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells.

Authors:  Yuan-Ji Day; Liping Huang; Marcia J McDuffie; Diane L Rosin; Hong Ye; Jiang-Fan Chen; Michael A Schwarzschild; J Stephen Fink; Joel Linden; Mark D Okusa
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

9.  Islet inflammation and hyperplasia induced by the pancreatic islet-specific overexpression of interleukin-6 in transgenic mice.

Authors:  I L Campbell; M V Hobbs; J Dockter; M B Oldstone; J Allison
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

10.  Defective macrophage antigen presentation following haemorrhage is associated with the loss of MHC class II (Ia) antigens.

Authors:  A Ayala; M M Perrin; I H Chaudry
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.